11 drug(s) with this reaction
10,045 total reports
Weight Decreased has been reported as an adverse reaction across 11 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 10,045 adverse event reports mention weight decreased in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with weight decreased, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have weight decreased listed in their FDA adverse event reports, sorted by report count:
In addition to weight decreased, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
11 drug(s) manufactured by Amgen Inc have weight decreased listed in their FDA adverse event reports: APREMILAST, DENOSUMAB, FILGRASTIM, PEGFILGRASTIM, DARBEPOETIN ALFA, and others.
There are a combined 10,045 reports of weight decreased across 11 Amgen Inc drug(s) in the FDA adverse event database.